Abstract
The aim of the present study was to investigate the influence of chronic treatment with haloperidol on the striatal N-methyl-D-aspartate (NMDA), α-amino-3-hydro-xy-5-methyl-4-isoxasole-propionic acid (AMPA) and dopamine D2 receptors using a quantitative autoradiography in rats. Haloperidol was given to animals in a dose of ca. 1 mg/kg/day in drinking water for 6 weeks or 3 months and was afterwards withdrawn for 5 days. Haloperidol increased by 20–50% the binding of [3H]spiperone in different regions of the caudate-putamen. Haloperidol decreased by ca. 30% the binding of [3H]AMPA in the ventrolateral region of intermediate part of the caudate-putamen, but did not influence the binding of [3H]MK-801. The present results suggest that, apart from supersensitivity to dopamine, chronic treatment with haloperidol also induces subsensitivity of striatal AMPA receptors.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Albin RJ, Makowiec RL, Hollingsworth ZR, Dure LS, Penney JB, Young AB (1992) Excitatory amino acid binding sites in the basal ganglia of the rat: a quantitative autoradiographic study. Neuroscience 46:35–48
Carlsson M, Carlsson A (1990) Interactions between glutamatergic and monoaminergic systems within the basal ganglia — implications for schizophrenia and Parkinson's disease. Trends Neurosci 13:272–276
Gerfen CR (1992) The neostriatal mosaic: multiple levels of compartmental organization. Trends Neurosci 15:133–139
Głażewski S, Skangiel-Kramska J, Kossut M (1993) Development of NMDA receptor-channel complex and L-type calcium channels in mouse hippocampus. J Neurosci Res 35:199–206
Greenamyre JT, Young AB (1989) Synaptic localization of striatal NMDA, quisqualate and kainate receptors. Neurosci Lett 101:133–137
Johnson AE, Liminga U, Lidén A, Lindefors N, Gunne LM, Wiesel FA (1994) Chronic treatment with a classical neuroleptics alters excitatory amino acid and GABAergic neurotransmission in specific regions of the rat brain. Neuroscience 63:1003–1020
Klockgether T, Turski L (1989) Excitatory amino acids and the basal ganglia: implications for the therapy of Parkinson's disease. Trends Neurosci 12:285–286
König JFR, Klippel RA (1963) The rat brain. Williams and Wilkins, Baltimore
Landwehrmeyer GB, Standaert DG, Testa CM, Penney JB, Young AB (1995) NMDA receptor subunit mRNA expression by projection neurons and interneurons in rat striatum. J Neurosci 15:5297–5307
Laurie DL, Seeburg PH (1994) Ligand affinities at recombinant N-methyl-D-aspartate receptors depend on subunit compositions. Eur J Pharmacol (Mol Pharmacol Sect) 268:335–345
Maura G, Giardi A, Raiteri M (1988) Release-regulating D-2 dopamine receptors are located on striatal glutamatergic nerve terminals. J Pharmacol Exp Ther 247:680–684
Moghaddam B, Bunney BS (1993) Depolarization inactivation of dopamine neurons: terminal release characteristics. Synapse 14:195–200
Monaghan DT, Olverman HJ, Nguyen L, Watkins JC, Cotman CW (1988) Two classes of N-methyl-D-aspartate recognition sites: differential distribution and differential regulation by glycine. Proc Natl Acad Sci USA 85:9836–9840
Ossowska K (1994) The role of excitatory amino acids in experimental models of Parkinson's disease. J Neural Transm [P-D Sect] 8:39–71
Ossowska K (1995) The subsensitivity of striatal glutamate receptors induced by chronic haloperidol in rats. Eur J Pharmacol 294:685–691
Ossowska K, Wolfarth S (1995) Stimulation of glutamate receptors in the intermediate/caudal striatum induces contralateral turning. Eur J Pharmacol 273:89–97
Ossowska K, Lorenc-Koci E, Schulze G, Wolfarth S (1996) The influence of dizocilpine (MK-801) on the reserpine-enhanced electromyographic stretch reflex in rats. Neurosci Lett 203:73–76
Riederer P, Lange KW, Kornhuber J, Danielczyk W (1992) Glutamatergic-dopaminergic balance in the brain. Arzneimittelforschung/Drug Res 42 (1):265–268
See RE, Chapman MA (1994) Chronic haloperidol, but not clozapine, produces altered oral movements and increased extracellular glutamate in rats. Eur J Pharmacol 263:269–276
See RE, Aravagiri M, Ellison GD (1989) Chronic neuroleptic treatment in rats produces persisting changes in GABAA and dopamine D-2, but not dopamine D-1 receptors. Life Sci 44:229–236
Smith AD, Bolam JP (1990) The neural network of the basal ganglia as revealed by the study of synaptic connections of identified neurones. Trends Neurosci 13:259–265
Tallaksen-Greene SJ, Wiley RG, Albin RL (1992) Localization of striatal excitatory amino acid binding site subtypes to strionigral projection neurons. Brain Res 594:165–170
Wolfarth S, Ossowska K (1989) Can the supersensitivity of rodents to dopamine be regarded as a model of tardive dyskinesia. Prog Neuro-Psychopharmacol Biol Psychiatry 13:799–840
Yamamoto BK, Davy S (1992) Dopaminergic modulation of glutamate release in striatum as measured by microdialysis. J Neurochem 58:1736–1742
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ossowska, K., Pietraszek, M. & Wardas, J. Further evidence for the subsensitivity of striatal AMPA receptors, induced by chronic haloperidol administration: an autoradiographic study. Naunyn-Schmiedeberg's Arch Pharmacol 354, 384–388 (1996). https://doi.org/10.1007/BF00171073
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00171073